OBP-801

DB12279InvestigationalSmall molecule

OBP-801 has been used in trials studying the treatment of Solid Tumor.

Chemical structure of OBP-801
Formula / weight
C20H31N3O6S2 · 473.6 g/mol (avg)
Code names
YM-753

Resolves to

Compound
UNII30Q3VS5HZ4CAS328548-11-4ChEMBLCHEMBL3126832PubChem11178958
Structure
InChIKeyXFLBOEMFLGLWFF-HDXRNPEWSA-NSMILESCC(C)[C@H]1NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C)C(=O)N2)OC(=O)C[C@@H]1O
Targets
Q13547HDAC1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
40Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with OBP-801, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In